| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00042307-200301000-00006 |
| P698 | PubMed publication ID | 12490813 |
| P2093 | author name string | Charlotte L Foley | |
| Roger S Kirby | |||
| P433 | issue | 1 | |
| P304 | page(s) | 31-37 | |
| P577 | publication date | 2003-01-01 | |
| P1433 | published in | Current Opinion in Urology | Q15746610 |
| P1476 | title | 5 alpha-reductase inhibitors: what's new? | |
| P478 | volume | 13 |
| Q44685341 | A comparison of the efficacy and tolerability of tamsulosin and finasteride in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia |
| Q53576123 | Androgen pathway manipulation and survival in patients with lung cancer. |
| Q44564369 | Androgenetic alopecia. Current aspects of a common phenotype |
| Q36300022 | Benign prostatic hyperplasia: an insight into current investigational medical therapies |
| Q36458457 | Chemoprevention of prostate cancer with finasteride |
| Q91356922 | Detection of 5α-reductase inhibitors by UPLC-MS/MS: Application to the definition of the excretion profile of dutasteride in urine |
| Q37785214 | Drug Development for Cancer Chemoprevention: Focus on Molecular Targets |
| Q58588902 | Drugs for benign prostatic hypertrophy |
| Q39881618 | Effect of short-term dutasteride therapy on prostate vascularity in patients with benign prostatic hyperplasia: a pilot study |
| Q37074396 | Effects of Melandrium firmum methanolic extract on testosterone-induced benign prostatic hyperplasia in Wistar rats |
| Q40279425 | Effects of the dual 5 alpha-reductase inhibitor dutasteride on apoptosis in primary cultures of prostate cancer epithelial cells and cell lines |
| Q36055841 | Fraction of macroporous resin from Smilax china L. inhibits testosterone propionate-induced prostatic hyperplasia in castrated rats |
| Q40505369 | Gene expression in prostate cancer cells treated with the dual 5 alpha-reductase inhibitor dutasteride |
| Q35194747 | Pharmacophylogenomics: genes, evolution and drug targets |
| Q36243696 | Risk of hip/femur fractures during the initiation period of α-adrenoceptor blocker therapy among elderly males: a self-controlled case series study |
| Q38231840 | Targeting the relaxin hormonal pathway in prostate cancer. |
| Q46300492 | Testosterone and the prostate: implications for the treatment of hypogonadal men. |
| Q26765196 | Understanding the molecular mechanisms of cancer prevention by dietary phytochemicals: From experimental models to clinical trials |
Search more.